iBio (IBIO) Net Income towards Common Stockholders (2016 - 2025)
Historic Net Income towards Common Stockholders for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$9.0 million.
- iBio's Net Income towards Common Stockholders fell 10607.24% to -$9.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$24.7 million, marking a year-over-year decrease of 8392.94%. This contributed to the annual value of -$18.4 million for FY2025, which is 9417.79% down from last year.
- Per iBio's latest filing, its Net Income towards Common Stockholders stood at -$9.0 million for Q4 2025, which was down 10607.24% from -$5.7 million recorded in Q3 2025.
- In the past 5 years, iBio's Net Income towards Common Stockholders ranged from a high of $51000.0 in Q2 2021 and a low of -$23.0 million during Q4 2022
- Moreover, its 5-year median value for Net Income towards Common Stockholders was -$5.0 million (2025), whereas its average is -$6.5 million.
- In the last 5 years, iBio's Net Income towards Common Stockholders soared by 10141.55% in 2021 and then crashed by 3353921.57% in 2022.
- Quarter analysis of 5 years shows iBio's Net Income towards Common Stockholders stood at -$11.9 million in 2021, then tumbled by 92.51% to -$23.0 million in 2022, then soared by 83.81% to -$3.7 million in 2023, then fell by 17.22% to -$4.4 million in 2024, then crashed by 106.07% to -$9.0 million in 2025.
- Its Net Income towards Common Stockholders stands at -$9.0 million for Q4 2025, versus -$5.7 million for Q3 2025 and -$5.2 million for Q2 2025.